Ikena Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ikena Oncology's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 41% to $9,160,000. Profit margin reached -744%. Total operating expenses were $84,577,000.
Profit Margin
| 2019 | 13.75M | -16.81M | -122.28% |
|---|---|---|---|
| 2020 | 9.19M | -44.25M | -481.36% |
| 2021 | 30.98M | -34.11M | -110.1% |
| 2022 | 15.61M | -66.62M | -426.6% |
| 2023 | 9.16M | -68.16M | -744.17% |
IKNA Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 9.16M | 15.61M | 30.98M | 9.19M | 13.75M |
Cost of revenue | 1.02M | 2.03M | 47.10M | 44.84M | 24.93M |
Gross profit | 8.14M | 13.58M | -16.12M | -35.65M | -11.18M |
Operating exp. | |||||
Research and development | 59.65M | 64.32M | 47.10M | 44.84M | 24.93M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 84.57M | 86.52M | 65.12M | 53.71M | 32.24M |
Operating income | -75.41M | -70.90M | -34.13M | -44.51M | -18.49M |
Other income (expenses), net | 7.08M | 2.13M | 23K | 263K | 1.67M |
Income before tax | -68.32M | -68.76M | -34.11M | -44.25M | -16.81M |
Income tax expense | -162K | -2.13M | 0 | 93.70K | 0 |
Net income | -68.16M | -66.62M | -34.11M | -44.25M | -16.81M |
Earnings per share | |||||
Basic EPS | -1.63 | -1.84 | -0.95 | -1.23 | -0.47 |
Diluted EPS | -1.63 | -1.84 | -0.95 | -1.23 | -0.47 |
| Data source | Data source | Data source |